Metagenomi, Inc. (MGX) Tops Q2 EPS by 18c

Metagenomi, Inc. (NASDAQ: MGX) reported Q2 EPS of ($0.54), $0.18 better than the analyst estimate of ($0.72). Revenue for the quarter came in at $8.51 million.

For earnings history and earnings-related data on Metagenomi, Inc. (MGX) click here.

You May Also Be Interested In

• Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
• Security Federal Corporation (SFDL) Declares $0.16 Quarterly Dividend; 1.5% Yield
• Moderna short sellers face $4.8 billion loss amid record stock jump